肥胖或胰岛素抵抗个体脂肪组织中盐诱导激酶2和3表达下调:对人脂肪细胞胰岛素信号和葡萄糖摄取的影响
研究检测人脂肪组织及脂肪细胞中盐诱导激酶(SIK)表达与肥胖、胰岛素抵抗的关系,并分析SIK2/3在TNF-α处理及沉默或抑制后对HDAC4、PKB/Akt磷酸化、GLUT4定位和葡萄糖摄取的影响。结果显示肥胖个体脂肪组织SIK2和SIK3 mRNA下调,SIK2与HOMA-IR负相关且不依赖BMI和年龄,沉默或抑制SIK1-3降低基础及胰岛素刺激的葡萄糖摄取。
要点
- 肥胖个体脂肪组织SIK2和SIK3 mRNA表达下调,且表达受体重变化调控。
- SIK2表达与HOMA-IR负相关,独立于BMI和年龄;SIK2蛋白水平及激酶活性与BMI负相关。
- 沉默或抑制SIK1-3降低HDAC4和PKB/Akt磷酸化、减少GLUT4膜定位及基础与胰岛素刺激的葡萄糖摄取。
核心结论
- 数据提示SIK可能对肥胖诱导的胰岛素抵抗的发展具有保护作用,并对未来治疗策略有启示。
研究设计与样本
- 检测人脂肪组织或脂肪细胞中SIK mRNA和蛋白并与临床变量做相关分析,在TNF-α处理的脂肪细胞中分析SIK2和SIK3表达与磷酸化,并用小干扰RNA沉默或泛SIK抑制剂HG-9-91-01抑制SIK后分析葡萄糖摄取、GLUT蛋白水平与定位、PKB/Akt及HDAC4磷酸化。
主要发现
- 肥胖个体脂肪组织SIK2和SIK3 mRNA下调,且表达受体重变化调控。
- SIK2与体内胰岛素抵抗(HOMA-IR)负相关,独立于BMI和年龄;SIK2蛋白水平及特异激酶活性与人脂肪细胞BMI负相关。
- 脂肪细胞中TNF-α下调SIK2和SIK3。
- 沉默或抑制脂肪细胞SIK1-3导致HDAC4和PKB/Akt磷酸化降低、质膜GLUT4减少、基础及胰岛素刺激的葡萄糖摄取降低。
临床怎么用
- 作者认为SIK可能对肥胖诱导的胰岛素抵抗的发展具有保护作用,并对未来治疗策略有启示。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Salt-inducible kinases (SIKs) are related to the metabolic regulator AMP-activated protein kinase (AMPK). SIK2 is abundant in adipose tissue. The aims of this study were to investigate the expression of SIKs in relation to human obesity and insulin resistance, and to evaluate whether changes in the expression of SIKs might play a causal role in the development of disturbed glucose uptake in human adipocytes. METHODS: SIK mRNA and protein was determined in human adipose tissue or adipocytes, and correlated to clinical variables. SIK2 and SIK3 expression and phosphorylation were analysed in adipocytes treated with TNF-α. Glucose uptake, GLUT protein levels and localisation, phosphorylation of protein kinase B (PKB/Akt) and the SIK substrate histone deacetylase 4 (HDAC4) were analysed after the SIKs had been silenced using small interfering RNA (siRNA) or inhibited using a pan-SIK-inhibitor (HG-9-91-01). RESULTS: We demonstrate that SIK2 and SIK3 mRNA are downregulated in adipose tissue from obese individuals and that the expression is regulated by weight change. SIK2 is also negatively associated with in vivo insulin resistance (HOMA-IR), independently of BMI and age. Moreover, SIK2 protein levels and specific kinase activity display a negative correlation to BMI in human adipocytes. Furthermore, SIK2 and SIK3 are downregulated by TNF-α in adipocytes. Silencing or inhibiting SIK1-3 in adipocytes results in reduced phosphorylation of HDAC4 and PKB/Akt, less GLUT4 at the plasma membrane, and lower basal and insulin-stimulated glucose uptake in adipocytes. CONCLUSION/INTERPRETATION: This is the first study to describe the expression and function of SIKs in human adipocytes. Our data suggest that SIKs might be protective in the development of obesity-induced insulin resistance, with implications for future treatment strategies.
引用
- Säll J, Pettersson AM, Björk C, et al. Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes. Diabetologia. 2016. PMID: 27807598. doi:10.1007/s00125-016-4141-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。